Zimmer Biomet Buys Paragon 28 For Approximately $1.1 Billion
Zimmer Biomet Holdings, Inc. announced that it entered into a definitive agreement to acquire all outstanding shares of common stock of Paragon 28, Inc. for an upfront payment of $13 per share in cash. This corresponds to an equity value of approximately $1.1 billion and an enterprise value of approximately $1.2 billion. Based in Englewood, Colorado, Paragon 28 is a medical device company exclusively focused on the foot and ankle orthopedic segment and is dedicated to improving patient lives. The company was established in 2010 to address unmet and under-served needs of the foot and ankle community. Paragon 28 provides orthopedic solutions, procedural approaches and instrumentation that... Read More »
Montagu Acquires Tyber Medical
Montagu Private Equity announced on January 14 the acquisition of Tyber Medical for an undisclosed price. With this transaction, Montagu will merge Tyber Medical with its portfolio companies Intech and Resolve Surgical Technologies to create a new platform. Tyber Medical is an orthopedic medical device manufacturer providing rapid access to FDA-cleared and CE-marked private label, regulatory-approved orthopedic implants for the spinal, extremity and trauma markets. Since it was founded in 2012, the company has released more than 50 spine, extremity and trauma systems. Montagu Private Equity is one of Europe’s leading private equity firms, with assets under... Read More »
Boston Scientific Announces its First Transaction of 2025 for $443 Million
Boston Scientific announced its first deal of 2025. On January 8, Boston Scientific reported that it was acquiring the remaining 74% stake of Bolt Medical for $443 million, plus potential regulatory milestone payments of up to $221 million. Bolt Medical is based in Carlsbad, California. It is a developer and manufacturer of an intravascular lithotripsy advanced laser-based platform for treating coronary and peripheral artery disease. The company is concurrently studying three unique catheter platforms for various arterial vessel beds. Boston Scientific helped establish Bold Medical in 2019 and prior to this transaction owned a 26% stake in the company. With headquarters... Read More »
Stryker Kicks Off 2025, Striking $4.9 Billion Inari Medical Deal
Medical device maker Stryker Corp. kicked off 2025 with a massive transaction. The Kalamazoo, Michigan-based company announced that it has agreed to acquire Inari Medical, headquartered in Irvine, California. Under the terms of the deal, which was first reported by Reuters on January 6, 2024, Stryker will pay $80 per share for Inari. The all-cash deal is worth $4.9 billion. Founded in 2013, Inari Medical Inc is a maker of devices and systems that treat patients suffering from a variety of blood clot conditions including pulmonary embolism, deep vein thrombosis and in-stent thrombosis, which occurs when blood clots form in the devices used to prop open coronary arteries that have been... Read More »
Boston Scientific to Acquire Intera Oncology
Boston Scientific Corporation announced on November 25 that it has entered into a definitive agreement to acquire Newton, Massachusetts-based Intera Oncology Inc. Intera Oncology is a privately held medical device company that provides the Intera 3000 Hepatic Artery Infusion Pump and floxuridine – a chemotherapy drug – both of which are approved by the U.S. Food and Drug Administration. The Intera 3000 pump is used to administer hepatic artery infusion therapy to treat tumors in the liver primarily caused by metastatic colorectal cancer. Boston Scientific develops and manufactures minimally invasive medical devices used in interventional cardiology, cardiac rhythm management, peripheral... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
